You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

guselkumab

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psoriasis of Scalp Trial in San Francisco (Guselkumab)

Recruiting
  • Psoriasis of Scalp
  • Guselkumab
  • San Francisco, California
    University of California San Francisco
May 4, 2023

Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab, Placebo)

Not yet recruiting
  • Psoriatic Arthritis
  • Guselkumab
  • +2 more
  • Philadelphia, Pennsylvania
    Hospital at the University of Pennsylvania
Dec 20, 2022

Psoriatic Arthritis Trial in Philadelphia (Guselkumab, Golimumab)

Not yet recruiting
  • Psoriatic Arthritis
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 18, 2022

Moderate Plaque Psoriasis Trial in Miami, Houston, San Antonio (Guselkumab, Placebo)

Recruiting
  • Moderate Plaque Psoriasis
  • Guselkumab
  • Placebo
  • Miami, Florida
  • +3 more
Sep 9, 2023

Psoriasis Vulgaris Trial in Belgium (Venapuncture, Patient questionnaires)

Recruiting
  • Psoriasis Vulgaris
  • Venapuncture
  • Patient questionnaires
  • Ghent, East-Flanders, Belgium
  • +6 more
Jan 16, 2023

Psoriasis Trial in Worldwide (Guselkumab)

Recruiting
  • Psoriasis
  • Guselkumab
  • Frankfurt, Germany
  • +7 more
Jan 17, 2023

Arthritis, Psoriatic, Healthy Trial in Graz (Guselkumab, Risankizumab)

Terminated
  • Arthritis, Psoriatic
  • Healthy
  • Graz, Austria
    Medical University Graz
Jul 22, 2022

Psoriasis Guttate, Plaque Psoriasis Trial in San Francisco (Guselkumab)

Recruiting
  • Psoriasis Guttate
  • Plaque Psoriasis
  • Guselkumab
  • San Francisco, California
    UCSF Psoriasis and Skin Treatment Center
Apr 28, 2022

Pityriasis Rubra Pilaris Trial in Portland (guselkumab)

Active, not recruiting
  • Pityriasis Rubra Pilaris
  • guselkumab
  • Portland, Oregon
    Oregon Health and Science University
Apr 8, 2022

Healthy Trial in Tempe, Mannheim (Guselkumab)

Completed
  • Healthy
  • Guselkumab
  • Tempe, Arizona
  • +1 more
Feb 2, 2022

Celiac Disease Trial in United States (Guselkumab, Placebo)

Withdrawn
  • Celiac Disease
  • Guselkumab
  • Placebo
  • Lancaster, California
  • +3 more
Jan 20, 2022

Healthy Trial in Berlin (Guselkumab)

Completed
  • Healthy
  • Guselkumab
  • Berlin, Germany
    CRS Clinical Research Services Berlin GmbH
Aug 25, 2021

Plaque Psoriasis, Scalp Psoriasis Trial in United States (Guselkumab, Placebo)

Not yet recruiting
  • Plaque Psoriasis
  • Scalp Psoriasis
  • Guselkumab
  • Placebo
  • Birmingham, Alabama
  • +11 more
Jun 16, 2022

Immunoclassification, Psoriasis Trial in Hangzhou (adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors,

Recruiting
  • Immunoclassification
  • Psoriasis
  • adalimumab, secukinumab, ixekizumab, guselkumab, Jak inhibitors, methotrexate
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 16, 2022

Psoriasis Trial in Canada, United States (Guselkumab, Placebo)

Recruiting
  • Psoriasis
  • Guselkumab
  • Placebo
  • Boston, Massachusetts
  • +4 more
Sep 29, 2022

Psoriasis Trial in Cleveland (Ustekinumab)

Not yet recruiting
  • Psoriasis
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center
Jul 6, 2022

Alcoholic Liver Disease Trial in La Jolla (Guselkumab 30mg, Guselkumab 70mg, Guselkumab 100mg)

Recruiting
  • Alcoholic Liver Disease
  • Guselkumab 30mg
  • +2 more
  • La Jolla, California
    University of California, San Diego
May 3, 2021

Giant Cell Arteritis Trial in Worldwide (Guselkumab, Placebo)

Recruiting
  • Giant Cell Arteritis
  • Guselkumab
  • Placebo
  • Kansas City, Kansas
  • +33 more
Aug 11, 2022

Adenomatous Polyposis Coli Trial in Worldwide (Guselkumab, Placebo)

Completed
  • Adenomatous Polyposis Coli
  • Guselkumab
  • Placebo
  • Phoenix, Arizona
  • +31 more
Jul 14, 2022

Skin Inflammation, Allergic Contact Dermatitis Trial in Worcester (drug, other, device)

Recruiting
  • Skin Inflammation
  • Allergic Contact Dermatitis
  • Squaric Acid Dibutyl Ester
  • +12 more
  • Worcester, Massachusetts
    University of Massachusetts Chan Medical School
Sep 6, 2022

Plaque Psoriasis, Psoriasis Vulgaris, Psoriasis Trial in Worldwide (Brodalumab, Placebo, Guselkumab)

Completed
  • Plaque Psoriasis
  • +2 more
  • Brodalumab
  • +2 more
  • Wien, Austria
  • +52 more
Jan 11, 2023

Psoriasis Trial in Worldwide (Guselkumab 100 mg, Placebo)

Completed
  • Psoriasis
  • Guselkumab 100 mg
  • Placebo
  • Bordeaux, France
  • +25 more
Dec 30, 2021

Healthy Trial in Beijing (Guselkumab (SC): Dose 1, Guselkumab (SC): Dose 2, Guselkumab (IV): Dose 1)

Completed
  • Healthy
  • Guselkumab (SC): Dose 1
  • +4 more
  • Beijing, China
    Peking University Third Hospital
Jan 27, 2021

Arthritis, Juvenile Trial in Worldwide (Ustekinumab, Guselkumab)

Recruiting
  • Arthritis, Juvenile
  • Birmingham, Alabama
  • +50 more
Jan 31, 2023

Psoriasis Trial in France, Germany (Guselkumab, Placebo Injection)

Active, not recruiting
  • Psoriasis
  • Guselkumab
  • Placebo Injection
  • Antony, France
  • +89 more
Jan 17, 2023